Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

APPROVED??? On October 22, 2020, FDA approved Veklury (remdesivir) for use in adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization. ~ FDA

https://www.fda.gov/drugs/drug-safety-and-availability/fdas-approval-veklury-remdesivir-treatment-covid-19-science-safety-and-effectiveness

Remdesivir’s approval was based on a Phase 3 study run by the National Institute of Allergy and Infectious Diseases, which concluded that the drug shortens recovery time for hospitalized COVID-19 patients by a few days. Yet interim results from a World Health Organization study suggest that remdesivir has no benefits.

https://cen.acs.org/pharmaceuticals/drug-discovery/Is-drug-repurposing-worth-the-effort/99/i3